查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433315

全球经导管肺动脉瓣市场 2023-2030

Global Transcatheter Pulmonary Valve Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 205 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期（2023-2030年），全球经导管肺动脉瓣市场将以7.3%的CAGR成长。市场成长的关键因素包括风湿性心臟病、高血压性心臟病、脑血管疾病和发炎性心臟病等各种心血管疾病（CVD）盛行率的增加。心臟瓣膜疾病人口的不断增长和肺动脉瓣置换需求的激增是支持市场成长的主要因素。根据世界卫生组织 (WHO) 统计，2019 年估计有 1,790 万人死于心血管疾病，占全球死亡率的 32%。每年有超过 288,348 人死于风湿性心臟病，其中大部分生活在低收入或中等收入国家。据估计，全球有 12.8 亿 30 至 79 岁的成年人患有高血压，其中约三分之二居住在低收入和中等收入国家。此外，估计 46% 的成人高血压患者并不知道自己患有这种疾病。

细分市场前景

全球经导管肺动脉瓣市场根据技术和应用进行细分。根据技术，市场分为球囊扩张式经导管瓣膜和自扩张式经导管瓣膜。此外，根据应用，市场细分为心臟异常、肺动脉闭锁、肺动脉狭窄、肺动脉瓣逆流等。其中，其他包括法洛氏四合症、动脉干四联症。在这些应用中，肺动脉瓣狭窄子细分市场预计将占据相当大的市场份额，因为其治疗主动脉瓣狭窄和主动脉瓣逆流的可行性增强，且手术併发症发生率较低。

预计球囊扩张经导管肺动脉瓣细分市场将在全球经导管肺动脉瓣市场中占据相当大的份额

在这些产品中，球囊扩张经导管瓣膜细分市场预计将在预测期内成长。此细分市场的成长归因于球囊扩张经导管瓣膜的采用率不断提高以及产品开发和技术进步的数量不断增加。因此，製造商被製造气球膨胀技术所吸引，这反过来又推动了市场的成长。根据爱思唯尔 JACC：亚洲杂誌代表美国心臟病学会基金会于 2021 年 9 月发表的文章，新一代球囊扩张瓣膜 (BEV) 似乎是手术的有效替代方案，特别是在一些亚洲国家二尖瓣主动脉瓣的盛行率较高。适用于BEV 的多功能技术可以安全地治疗异常、严重钙化、较大的环形BAV，这些BAV 因室週白质软化(PVL)、冠状动脉阻塞、质子帮浦抑制剂(PPI) 和主动脉破裂的高风险而被认为不适合TAVR。

区域展望

全球经导管肺动脉瓣市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于对创新心臟瓣膜的需求不断增长、老年人口不断增加以及医疗保健支出不断增加，预计亚太地区将在预测期内实现增长。

北美地区预计全球经导管肺动脉瓣市场将以显着的CAGR成长

由于医疗保健产业发达，以及肺动脉瓣狭窄和逆流等疾病盛行率不断上升，预计北美将在经导管肺动脉瓣市场占据显着份额。此外，人们对创新心臟瓣膜的认识不断提高，需求不断增加，加上医疗保健支出不断增加，预计将在预测期内推动市场成长。根据经济合作暨发展组织（OECD）的数据，2021年，美国医疗保健支出占国内生产毛额（GDP）的17.8%，几乎是经合组织国家平均水准的两倍。

根据美国医疗保险和医疗补助服务中心 (CMMS) 2022 年 3 月发布的资料，报告发现，2021-2030 年国民医疗支出年均增长预计为 5.1%，到 2030 年将达到近 6.8 兆美元同期国家国内生产毛额的年增长率预计为5.1%。根据可比较的预测成长率，预计 2030 年医疗保健占 GDP 的份额将为 19.6%，与 2020 年 19.7% 的份额几乎相同。因此，预计该国不断增长的医疗保健支出将推动公司活动和政府在开发高效经导管肺动脉瓣方面的倡议，从而促进市场成长。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Boston Scientific Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Braile Biomedica
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Medtronic PLC
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Edwards Lifesciences Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按技术分類的全球经导管肺动脉瓣市场
    • 球囊扩张经导管瓣膜
    • 自膨胀式经导管瓣膜
  • 全球经导管肺动脉瓣市场（按应用）
    • 心臟异常
    • 肺动脉闭锁
    • 肺动脉狭窄
    • 肺动脉瓣逆流
    • 其他（法洛氏四合症、动脉干）

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • 4C Medical Technologies, Inc.,
  • Abott laboratories
  • Artivion, Inc.
  • Colibri Heart Valve, LLC
  • Cryolife, Inc.
  • Direct Flow Medical, Inc.
  • JenaValve Technology, Inc.
  • Jude Medical Inc.
  • Labcor Laborateries Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • St. Jude Medical, Inc.
  • SYMETIS SA
  • Venus Medtech (Hangzhou) Inc.
  • Xeltis B.V.
Product Code: OMR2027939

Global Transcatheter Pulmonary Valve Market Size, Share & Trends Analysis Report by Technology (Balloon-Expanded Transcatheter Valve, and Self-Expanded Transcatheter Valve), and by Application (Cardiac Anomaly, Pulmonary Atresia, Pulmonary Stenosis, Pulmonary Regurgitation, and Others), Forecast Period (2023-2030)

The global transcatheter pulmonary valve market is anticipated to grow at a CAGR of 7.3% during the forecast period (2023-2030). Pivotal factors attributed to market growth including increasing prevalence of various cardiovascular diseases (CVDs) such as rheumatic heart disorders, hypertensive heart diseases, cerebrovascular diseases, and inflammatory heart diseases. The growing population with heart valve disorders and surging demand for pulmonary valve replacement are major factors supporting the market growth. According to the World Health Organization (WHO), an estimated 17.9 million people were deceased from CVDs in 2019, representing 32% of all global mortalities. Rheumatic heart disease and claims over 288,348 lives each year the large majority in low- or middle-income countries. An estimated 1.28 billion adults aged 30 to 79 years globally have hypertension, among which around two-thirds living in low and middle-income countries. In addition, an estimated 46% of adults with hypertension are unaware that they have the condition.

Segmental Outlook

The global transcatheter pulmonary valve market is segmented on the technology, and application. Based on the technology, the market is sub-segmented into balloon-expanded transcatheter valve and self-expanded transcatheter valve. Further, based on application, the market is sub-segmented into cardiac anomaly, pulmonary atresia, pulmonary stenosis, pulmonary regurgitation, and others. Where, others include tetralogy of fallot, truncusarteriosus. Among the application, the pulmonary stenosis sub-segment is anticipated to hold a considerable share of the market, owing to its enhanced feasibility of treating both aortic stenosis and aortic regurgitation with low rates of procedural complications.

The Balloon-Expanded Transcatheter Valve Sub-Segment is Anticipated to Hold a Considerable Share of the Global Transcatheter Pulmonary Valve Market

Among the products, balloon-expanded transcatheter valve sub-segment is expected to grow over the forecast period. The segmental growth is attributed to the increasing adoption rate for balloon-expanded transcatheter valve and the growing number of product development, and technical advancement. Thus, manufacturers are attracted towards manufacturing balloon-expanded technology which in turn is propelling the market growth. According to the article published by Elsevier JACC: Asia journal, on behalf of The American College of Cardiology Foundation, in September 2021, new-generation balloon-expandable valve (BEV) appeared to be a valid alternative to surgery, especially in some Asian countries with a higher prevalence of bicuspid aortic valve. Versatile techniques applied to BEV could treat anomaly, heavily calcified, larger annular BAVs safely, which were considered ineligible in TAVR due to high risk of Periventricular leukomalacia (PVL), coronary artery obstruction, Proton pump inhibitors (PPIs), and aortic rupture.

Regional Outlook

The global transcatheter pulmonary valve market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to grow over the forecast period, owing to the growing demand for innovative heart valves, increasing geriatric population, and rising healthcare expenditure.

The North America Region is Expected to Grow at a Significant CAGR in the Global Transcatheter Pulmonary Valve Market

North America is expected to hold a prominent share in the transcatheter pulmonary valve market, owing to the presence of a well-developed healthcare sector, along with the rising prevalence of disorders such as pulmonary stenosis and regurgitation. Additionally, rising awareness and increasing demand for innovative heart valves, along with the rising healthcare expenditure are some other factors projected to drive the market growth over the forecast period. According to the Organization for Economic Co-operation and Development (OECD), in 2021, the US spent 17.8% of gross domestic product (GDP) on healthcare, nearly twice as much as the average OECD country.

As per the data published by the Centers for Medicare & Medicaid Services (CMMS), in March 2022, the report found that annual growth in national health spending is expected to average 5.1% over 2021-2030, and will reach nearly $6.8 trillion by 2030. Growth in the nation's GDP is also projected to be 5.1% annually over the same period. As a result of the comparable projected rates of growth, the healthcare share of GDP is expected to be 19.6% in 2030, nearly the same as the 2020 share of 19.7%. Thus, the growing healthcare spending in the country is anticipated to push company activities and government initiatives in developing efficient transcatheter pulmonary valves, in turn bolstering the market growth.

Market Players Outlook

The major companies serving the global transcatheter pulmonary valve market include Boston Scientific Corp., Braile Biomedica, Medtronic PLC, Edwards Lifesciences Corp., Artivion, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2023, Medtronic PLC relaunched first-of-its-kind transcatheter pulmonary valve replacement system for treating congenital heart disease.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global transcatheter pulmonary valve market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Boston Scientific Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Braile Biomedica
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Medtronic PLC
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Edwards Lifesciences Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Transcatheter Pulmonary Valve Market by Technology
    • 4.1.1. Balloon-Expanded Transcatheter Valve
    • 4.1.2. Self-Expanded Transcatheter Valve
  • 4.2. Global Transcatheter Pulmonary Valve Market by Application
    • 4.2.1. Cardiac Anomaly
    • 4.2.2. Pulmonary Atresia
    • 4.2.3. Pulmonary Stenosis
    • 4.2.4. Pulmonary Regurgitation
    • 4.2.5. Others (Tetralogy of Fallot, Truncus Arteriosus)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 4C Medical Technologies, Inc.,
  • 6.2. Abott laboratories
  • 6.3. Artivion, Inc.
  • 6.4. Colibri Heart Valve, LLC
  • 6.5. Cryolife, Inc.
  • 6.6. Direct Flow Medical, Inc.
  • 6.7. JenaValve Technology, Inc.
  • 6.8. Jude Medical Inc.
  • 6.9. Labcor Laborateries Ltd.
  • 6.10. Lepu Medical Technology (Beijing) Co., Ltd.
  • 6.11. LivaNova PLC
  • 6.12. St. Jude Medical, Inc.
  • 6.13. SYMETIS SA
  • 6.14. Venus Medtech (Hangzhou) Inc.
  • 6.15. Xeltis B.V.

LIST OF TABLES

  • 1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 2. GLOBAL BALLOON-EXPANDED TRANSCATHETER VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL SELF-EXPANDED TRANSCATHETER VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL TRANSCATHETER PULMONARY VALVE FOR CARDIAC ANOMALY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY ATRESIA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY STENOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY REGURGITATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL TRANSCATHETER PULMONARY VALVE FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 14. EUROPEAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. EUROPEAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 16. EUROPEAN TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
  • 2. GLOBAL BALLOON-EXPANDED TRANSCATHETER VALVE MARKET SHARE BY MATERIAL, 2022 VS 2030 (%)
  • 3. GLOBAL SELF-EXPANDED TRANSCATHETER VALVE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL TRANSCATHETER PULMONARY VALVE FOR CARDIAC ANOMALY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY ATRESIA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY STENOSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL TRANSCATHETER PULMONARY VALVE FOR PULMONARY REGURGITATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL TRANSCATHETER PULMONARY VALVE FOR OTHER APPLICATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. US TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. UK TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. REST OF EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2022-2030 ($ MILLION)